Alcon, a Switzerland-based eye care company, is teed up to acquire Durham, N.C.-based Aerie Pharmaceuticals for about $770 million after approval from each company’s board of directors Aug. 22.
Read the full post on Becker's Hospital Review - Healthcare News
